Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OrbiMed
Biotech
Alentis raises $181M series D to bring ADCs to the clinic
Swiss biotech Alentis Therapeutics has secured $181 million, money that will be used to launch clinical trials for two ADCs.
Gabrielle Masson
Nov 12, 2024 7:00am
Capitalizing on ADC frenzy, ProfoundBio attracts $112M series B
Feb 13, 2024 7:00am
Flagship CEO says firm has work to do before inking China pacts
Jan 8, 2024 9:05pm
Troubled Theseus mulls bids from both OrbiMed and Concentra
Nov 27, 2023 9:31am
OrbiMed nets $4.3B across 3 funds
Oct 24, 2023 7:30am
Mini heart pump maker Magenta Medical collects $55M
May 3, 2023 8:00am
